Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 1274034, 8 pages
https://doi.org/10.1155/2017/1274034
Review Article

Cardiovascular Disease in Ageing: An Overview on Thoracic Aortic Aneurysm as an Emerging Inflammatory Disease

1Cardiac Surgery Unit, “P. Giaccone” University Hospital, Palermo, Italy
2Department of Pathobiology and Medical and Forensic Biotechnologies, University of Palermo, Palermo, Italy
3Cardiac Surgery Unit, Tor Vergata University Hospital, Rome, Italy

Correspondence should be addressed to Calogera Pisano; ti.orebil@ipilacab

Received 29 June 2017; Revised 16 September 2017; Accepted 28 September 2017; Published 24 October 2017

Academic Editor: Giuseppe Valacchi

Copyright © 2017 Calogera Pisano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. G. Lakatta and S. J. Sollott, “Perspectives on mammalian cardiovascular aging: humans to molecules,” Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, vol. 132, pp. 699–721, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. E. G. Lakatta and D. Levy, “Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease,” Circulation, vol. 107, no. 2, pp. 346–354, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Fulop, A. Larbi, J. M. Witkowski et al., “Aging, frailty and age-related diseases,” Biogerontology, vol. 11, no. 5, pp. 547–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Braunwald, “The war against heart failure: the lancet lecture,” The Lancet, vol. 385, no. 9970, pp. 812–824, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. A. Chiao and P. S. Rabinovitch, “The aging heart,” Cold Spring Harbor Perspectives in Medicine, vol. 7, no. 9, article a025148, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. F. Dai, T. Chen, S. C. Johnson, H. Szeto, and P. S. Rabinovitch, “Cardiac aging: from molecular mechanisms to significance in human health and disease,” Antioxidants & Redox Signaling, vol. 16, no. 12, pp. 1492–1536, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Steenman and G. Lande, “Cardiac aging and heart disease in humans,” Biophysical Reviews, vol. 9, no. 2, pp. 131–137, 2017. View at Publisher · View at Google Scholar
  8. K. Sharma and D. A. Kass, “Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies,” Circulation Research, vol. 115, no. 1, pp. 79–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Keller and S. E. Howlett, “Sex differences in the biology and pathology of the aging heart,” Canadian Journal of Cardiology, vol. 32, no. 9, pp. 1065–1073, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. J. B. Strait and E. G. Lakatta, “Aging-associated cardiovascular changes and their relationship to heart failure,” Heart Failure Clinics, vol. 8, no. 1, pp. 143–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. A. Feridooni, A. E. Kane, O. Ayaz et al., “The impact of age and frailty on ventricular structure and function in C57BL/6J mice,” The Journal of Physiology, vol. 595, no. 12, pp. 3721–3742, 2017. View at Publisher · View at Google Scholar
  12. A. M. Katz and E. L. Rolett, “Heart failure: when form fails to follow function,” European Heart Journal, vol. 37, no. 5, pp. 449–454, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. C. S. Lam, M. Rienstra, W. T. Tay et al., “Atrial fibrillation in heart failure with preserved ejection fraction: association with exercise capacity, left ventricular filling pressures, natriuretic peptides, and left atrial volume,” JACC: Heart Failure, vol. 5, no. 2, pp. 92–98, 2017. View at Publisher · View at Google Scholar
  14. H. Yamada, N. Sakata, H. Wada, T. Tashiro, and E. Tayama, “Age-related distensibility and histology of the ascending aorta in elderly patients with acute aortic dissection,” Journal of Biomechanics, vol. 48, no. 12, pp. 3267–3273, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. M. S. Dzeshka, G. Y. Lip, V. Snezhitskiy, and E. Shantsila, “Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications,” Journal of the American College of Cardiology, vol. 66, no. 8, pp. 943–959, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. C. R. Balistreri, E. Maresi, C. Pisano et al., “Identification of three particular morphological phenotypes in sporadic thoracic aortic aneurysm: phenotype III as sporadic thoracic aortic aneurysm biomarker in aged individuals,” Rejuvenation Research, vol. 17, no. 2, pp. 192–196, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Rapezzi, G. Merlini, C. C. Quarta et al., “Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types,” Circulation, vol. 120, no. 13, pp. 1203–1212, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. van Ooij, J. Garcia, W. V. Potters et al., “Age-related changes in aortic 3D blood flow velocities and wall shear stress: implications for the identification of altered hemodynamics in patients with aortic valve disease,” Journal of Magnetic Resonance Imaging, vol. 43, no. 5, pp. 1239–1249, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. C. R. Balistreri, “Genetic contribution in sporadic thoracic aortic aneurysm? Emerging evidence of genetic variants related to TLR-4-mediated signaling pathway as risk determinants,” Vascular Pharmacology, vol. 74, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. C. R. Balistreri, C. Pisano, T. D'Amico et al., “The role of inflammation in type A aortic dissection: data of a pilot study,” European Journal of Inflammation, vol. 11, pp. 269–278, 2013. View at Publisher · View at Google Scholar
  21. I. El-Hamamsy and M. Yacoub, “Cellular and molecular mechanisms of thoracic aortic aneurysms,” Nature Reviews Cardiology, vol. 6, no. 12, pp. 771–786, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. He, D. C. Guo, A. L. Estrera et al., “Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections,” The Journal of Thoracic and Cardiovascular Surgery, vol. 131, no. 3, pp. 671–678.e2, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Ruvolo, C. Pisano, G. Candore et al., “Can the TLR-4-mediated signaling pathway be a key inflammatory promoter for sporadic TAA?” Mediators of Inflammation, vol. 2014, Article ID 349476, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Pisano, E. Maresi, C. R. Balistreri et al., “Histological and genetic studies in patients with bicuspid aortic valve and ascending aorta complications,” Interactive CardioVascular and Thoracic Surgery, vol. 14, no. 3, pp. 300–306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Pisano, E. Maresi, D. Merlo et al., “A particular phenotype of ascending aorta aneurysms as precursor of type A aortic dissection,” Interactive Cardiovascular and Thoracic Surgery, vol. 15, no. 5, pp. 840–846, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Ihling, T. Szombathy, K. Nampoothiri et al., “Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation,” Heart, vol. 82, no. 3, pp. 286–293, 1999. View at Publisher · View at Google Scholar
  27. L. F. Hiratzka, M. A. Creager, E. M. Isselbacher et al., “2010 F/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease representative members, 2014 AHA/ACC guideline for the management of patients with valvular heart disease representative members, Sundt TM 3rd,” The Journal of Thoracic and Cardiovascular Surgery, vol. 151, no. 4, pp. 959–966, 2016. View at Google Scholar
  28. C. Pisano, C. Rita Balistreri, O. Fabio Triolo, V. Argano, and G. Ruvolo, “Acute type A aortic dissection: beyond the diameter,” The Journal of Heart Valve Disease, vol. 25, no. 6, pp. 764–768, 2016. View at Google Scholar
  29. C. R. Balistreri, C. Caruso, F. Listì, G. Colonna-Romano, D. Lio, and G. Candore, “LPS-mediated production of pro/anti-inflammatory cytokines and eicosanoids in whole blood samples: biological effects of +896A/G TLR4 polymorphism in a Sicilian population of healthy subjects,” Mechanisms of Ageing and Development, vol. 132, no. 3, pp. 86–92, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Kato, Y. Tatara, M. Ohishi et al., “Angiotensin-converting enzyme single nucleotide polymorphism is a genetic risk factor for cardiovascular disease: a cohort study of hypertensive patients,” Hypertension Research, vol. 34, no. 6, pp. 728–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Zhang, Y. H. Shen, and S. A. Le Maire, “Thoracic aortic dissection: are matrix metalloproteinases involved?” Vascular, vol. 17, no. 3, pp. 147–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. P. S. Silva, R. Lacchini, A. Gomes Vde, and J. E. Tanus-Santos, “Pharmacogenetic implications of the eNOS polymorphisms for cardiovascular action drugs,” Arquivos Brasileiros de Cardiologia, vol. 96, no. 2, pp. e27–e34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Andelfinger, B. Loeys, and H. Dietz, “A decade of discovery in the genetic understanding of thoracic aortic disease,” Canadian Journal of Cardiology, vol. 32, no. 1, pp. 13–25, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Scola, F. M. Di Maggio, and L. Vaccarino, “Role of TGF-β pathway polymorphisms in sporadic thoracic aortic aneurysm: rs900 TGF-β2 is a marker of differential gender susceptibility,” Mediators of Inflammation, vol. 2014, Article ID 165758, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Kurtovic, V. Paloschi, L. Folkersen, J. Gottfries, A. Franco-Cereceda, and P. Eriksson, “Diverging alternative splicing fingerprints in the transforming growth factor-β signaling pathway identified in thoracic aortic aneurysms,” Molecular Medicine, vol. 17, no. 7-8, pp. 665–675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Wu, Y. H. Shen, L. Russell, J. S. Coselli, and S. A. LeMaire, “Molecular mechanisms of thoracic aortic dissection,” The Journal of Surgical Research, vol. 184, no. 2, pp. 907–924, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. E. Lindsay and H. C. Dietz, “Lessons on the pathogenesis of aneurysm from heritable conditions,” Nature, vol. 473, no. 7347, pp. 308–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. D. G. Molin, D. R. MC, L. J. Wisse et al., “Altered apoptosis pattern during pharyngeal arch artery remodelling is associated with aortic arch malformations in Tgfβ2 knock-out mice,” Cardiovascular Research, vol. 56, no. 2, pp. 312–322, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Lindsay, D. Schepers, N. A. Bolar et al., “Loss-of-function mutations in TGFΒ2 cause a syndromic presentation of thoracic aortic aneurysm,” Nature Genetics, vol. 44, no. 8, pp. 922–927, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Maleszewska, J. R. Moonen, N. Huijkman, B. van de Sluis, G. Krenning, and M. C. Harmsen, “IL-1β and TGF-β2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner,” Immunobiology, vol. 218, no. 4, pp. 443–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Pannu, V. T. Fadulu, J. Chang et al., “Mutations in transforming growth factor-β receptor type II cause familial thoracic aortic aneurysms and dissections,” Circulation, vol. 112, no. 4, pp. 513–520, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. R. J. Akhurst, “The paradoxical TGF-β vasculopathies,” Nature Genetics, vol. 44, no. 8, pp. 838-839, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Li, N. Luo, Z. Bai, S. Wang, Y. Shi, and X.’e. Fa, “A canine model of multiple organ dysfunction following acute type-A aortic dissection,” Surgery Today, vol. 42, no. 9, pp. 876–883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Ju, T. Ijaz, H. Sun et al., “IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome,” Journal of the American Heart Association, vol. 3, no. 1, article e000476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Wen, X.-L. Zhou, J.-J. Li et al., “Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-α and matrix metalloproteinase-9 in aortic dissection,” Clinica Chimica Acta, vol. 413, pp. 198–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Kasashima, A. Kawashima, Y. Zen et al., “Upregulated interleukins (IL-6, IL-10, and IL-13) in immunoglobulin G4-related aortic aneurysm patients,” Journal of Vascular Surgery, vol. 20, 2017. View at Publisher · View at Google Scholar
  47. A. Gallo, A. Saad, R. Ali, A. Dardik, G. Tellides, and A. Geirsson, “Circulating interferon-γ-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice,” The Journal of Thoracic and Cardiovascular Surgery, vol. 143, no. 3, pp. 704–710, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Zhou, G. Xiu, Y. Zhu et al., “Bone marrow mesenchymal stem cells modulated the inflammatory response by regulating the expression of IL-4 and RAGE products in the rats with MODS,” Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, vol. 29, no. 4, pp. 294–299, 2017. View at Publisher · View at Google Scholar
  49. S. Makita, A. Ohira, R. Tachieda et al., “Behavior of C-reactive protein levels in medically treated aortic dissection and intramural hematoma,” The American Journal of Cardiology, vol. 86, no. 2, pp. 242–244, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Schillinger, H. Domanovits, K. Bayegan et al., “C-reactive protein and mortality in patients with acute aortic disease,” Intensive Care Medicine, vol. 28, no. 6, pp. 740–745, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. M. Yuan, Y. H. Shi, J. J. Wang, F. Q. Lü, and S. Gao, “Elevated plasma D-dimer and hypersensitive C-reactive protein levels may indicate aortic disorders,” Revista Brasileira de Cirurgia Cardiovascular, vol. 26, no. 4, pp. 573–581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Wen, H. Y. Wu, X. J. Jiang et al., “Role of plasma C-reactive protein and white blood cell count in predicting in-hospital clinical events of acute type A aortic dissection,” Chinese Medical Journal, vol. 124, no. 17, pp. 2678–2682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Sakakura, N. Kubo, J. Ako et al., “Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection,” Hypertension, vol. 55, no. 2, pp. 422–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Ohlmann, O. Morel, B. Radulescu et al., “D-dimer in ruling out acute aortic dissection: sensitivity is not 100%,” European Heart Journal, vol. 29, no. 6, pp. 828-829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Sodeck, H. Domanovits, M. Schillinger et al., “D-dimer in ruling out acute aortic dissection: a systematic review and prospective cohort study,” European Heart Journal, vol. 28, no. 24, pp. 3067–3075, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. T. Suzuki, A. Distante, A. Zizza et al., “Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience,” Circulation, vol. 119, no. 20, pp. 2702–2707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Paparella, P. G. Malvindi, G. Scrascia et al., “D-dimers are not always elevated in patients with acute aortic dissection,” Journal of Cardiovascular Medicine, vol. 10, pp. 212–214, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Ohlmann, A. Faure, O. Morel et al., “Lower circulating Sta-Liatest D-Di levels in patients with aortic intramural hematoma compared with classical aortic dissection,” Critical Care Medicine, vol. 37, no. 3, pp. 899–901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Hazui, M. Nishimoto, M. Hoshiga et al., “Young adult patients with short dissection length and thrombosed false lumen without ulcer-like projections are liable to have false-negative results of D-dimer testing for acute aortic dissection based on a study of 113 cases,” Circulation Journal, vol. 70, no. 12, pp. 1598–1601, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Hazui, H. Fukumoto, N. Negoro et al., “Simple and useful tests for discriminating between acute aortic dissection of the ascending aorta and acute myocardial infarction in the emergency setting,” Circulation Journal, vol. 69, no. 6, pp. 677–682, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Nagaoka, K. Sadamatsu, T. Yamawaki et al., “Fibrinogen/fibrin degradation products in acute aortic dissection,” Internal Medicine, vol. 49, no. 18, pp. 1943–1947, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Jo, T. Anzai, K. Ueno et al., “Re-elevation of D-dimer as a predictor of re-dissection and venous thromboembolism after Stanford type B acute aortic dissection,” Heart and Vessels, vol. 25, no. 6, pp. 509–514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Shimony, K. B. Filion, S. Mottillo, T. Dourian, and M. J. Eisenberg, “Meta-analysis of usefulness of d-dimer to diagnose acute aortic dissection,” The American Journal of Cardiology, vol. 107, no. 8, pp. 1227–1234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Kumar, T. Kawai, and S. Akira, “Toll-like receptors and innate immunity,” Biochemical and Biophysical Research Communications, vol. 388, no. 4, pp. 621–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. C. R. Balistreri, G. Ruvolo, D. Lio, and R. Madonna, “Toll-like receptor-4 signaling pathway in aorta aging and diseases: “its double nature”,” Journal of Molecular and Cellular Cardiology, vol. 110, pp. 38–53, 2017. View at Publisher · View at Google Scholar
  66. M. M. Bachschmid, S. Schildknecht, R. Matsui et al., “Vascular aging: chronic oxidative stress and impairment of redox signaling—consequences for vascular homeostasis and disease,” Annals of Medicine, vol. 45, no. 1, pp. 17–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Wang, R. E. Monticone, and E. G. Lakatta, “Arterial aging: a journey into subclinical arterial disease,” Current Opinion in Nephrology and Hypertension, vol. 19, no. 2, pp. 201–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. C. R. Balistreri, G. Candore, G. Accardi, G. Colonna-Romano, and D. Lio, “NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies,” Immunity & Ageing, vol. 10, no. 1, article 24, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. B. C. Tieu, C. Lee, H. Sun et al., “An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3637–3651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Kurobe, Y. Matsuoka, Y. Hirata et al., “Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects,” The Journal of Thoracic and Cardiovascular Surgery, vol. 146, no. 6, pp. 1501–1508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Takemura, K. Iijima, H. Ota et al., “Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells,” Arteriosclerosis, Thrombosis and Vascular Biology, vol. 31, no. 9, pp. 2054–2062, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. W. F. Johnston, M. Salmon, N. H. Pope et al., “Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms,” Circulation, vol. 9, 11 Supplement 1, no. 130, pp. S51–S59, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. E. A. Slee, H. Zhu, S. C. Chow, M. MacFarlane, D. W. Nicholson, and G. M. Cohen, “Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD. FMK) inhibits apoptosis by blocking the processing of CPP32,” Biochemical Journal, vol. 315, Part 1, pp. 21–24, 1996. View at Publisher · View at Google Scholar
  74. F. Martinon, K. Burns, and J. Tschopp, “The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. D. Wu, P. Albini, G. Xu et al., “Nlrp3 inflammasome is upregulated in thoracic aortic aneurysms and dissections,” Journal of Surgical Research, vol. 172, p. 280, 2012. View at Publisher · View at Google Scholar
  76. A. Yamawaki-Ogata, R. Hashizume, X. M. Fu, A. Usui, and Y. Narita, “Mesenchymal stem cells for treatment of aortic aneurysms,” World Journal of Stem Cells, vol. 6, no. 3, pp. 278–287, 2014. View at Publisher · View at Google Scholar
  77. J. A. Elefteriades, “Thoracic aortic aneurysm: reading the enemy’s playbook,” The Yale Journal of Biology and Medicine, vol. 81, no. 4, pp. 175–186, 2008. View at Google Scholar
  78. K. Satoh, P. Nigro, and B. C. Berk, “Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A,” Antioxidants & Redox Signaling, vol. 12, no. 5, pp. 675–682, 2010. View at Publisher · View at Google Scholar · View at Scopus